Foviscu (WCK 4282) - Phase 3 Ongoing First-line empiric treatment for gram-negative hospital infections (cUTI, HABP/VABP) Complements ZAYNICH: while ZAYNICH is the destination therapy at the top of the pyramid for resistant infections, Foviscu is the entry-level, broad-use first drug of choice Global Phase 3 trial underway If approved, the commercial TAM is significantly larger than ZAYNICH due to broader use 5
Store Rybelsus in a dry place away from moisture
Desikan SP, Konopleva M, Takahashi K, Lachowiez CA, Loghavi S, MD, Xiao L, Kadia TM, MD, Daver N, MD, Short N, MD, Sasaki K, MD, Borthakur G, MD, Ghayas C Issa GC, Maiti A, Chien KS, Alvarado Y, Montalban-Bravo G, Masarova L, Yilmaz M, Andreeff M , Jabbour E, Garcia-Manero G, Kornblau SM, Ravandi F, Kantarjian H, and DiNardo CD
They pack a whopping 17g of protein per serving and are made with cage-free eggs perfect for busy mornings
Mix one packet with 8 oz of water and take once or twice daily with a meal, or as directed by your healthcare professional
Supplements are not regulated by the FDA in the same way as prescription drugs
